These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 10603099

  • 21. Hereditary tyrosinemia type 1 from a single center in Egypt: clinical study of 22 cases.
    El-Karaksy H, Fahmy M, El-Raziky M, El-Koofy N, El-Sayed R, Rashed MS, El-Kiki H, El-Hennawy A, Mohsen N.
    World J Pediatr; 2011 Aug; 7(3):224-31. PubMed ID: 21633861
    [Abstract] [Full Text] [Related]

  • 22. Factors affecting growth after pediatric liver transplantation.
    McDiarmid SV, Gornbein JA, DeSilva PJ, Goss JA, Vargas JH, Martín MG, Ament ME, Busuttil RW.
    Transplantation; 1999 Feb 15; 67(3):404-11. PubMed ID: 10030286
    [Abstract] [Full Text] [Related]

  • 23. Late hepatic artery thrombosis after orthotopic liver transplantation.
    Gunsar F, Rolando N, Pastacaldi S, Patch D, Raimondo ML, Davidson B, Rolles K, Burroughs AK.
    Liver Transpl; 2003 Jun 15; 9(6):605-11. PubMed ID: 12783403
    [Abstract] [Full Text] [Related]

  • 24. Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.
    Ghobrial RM, Farmer DG, Baquerizo A, Colquhoun S, Rosen HR, Yersiz H, Markmann JF, Drazan KE, Holt C, Imagawa D, Goldstein LI, Martin P, Busuttil RW.
    Ann Surg; 1999 Jun 15; 229(6):824-31; discussion 831-3. PubMed ID: 10363896
    [Abstract] [Full Text] [Related]

  • 25. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.
    Jain A, Reyes J, Kashyap R, Rohal S, Abu-Elmagd K, Starzl T, Fung J.
    Ann Surg; 1999 Sep 15; 230(3):441-8; discussion 448-9. PubMed ID: 10493490
    [Abstract] [Full Text] [Related]

  • 26. Emotional and behavioral problems, quality of life and metabolic control in NTBC-treated Tyrosinemia type 1 patients.
    van Vliet K, van Ginkel WG, Jahja R, Daly A, MacDonald A, De Laet C, Vara R, Rahman Y, Cassiman D, Eyskens F, Timmer C, Mumford N, Bierau J, van Hasselt PM, Gissen P, Goyens PJ, McKiernan PJ, Wilcox G, Morris AAM, Jameson EA, Huijbregts SCJ, van Spronsen FJ.
    Orphanet J Rare Dis; 2019 Dec 04; 14(1):285. PubMed ID: 31801588
    [Abstract] [Full Text] [Related]

  • 27. Clinical utilization of dried blood spot nitisinone (NTBC) and succinylacetone (SA) concentrations in hereditary tyrosinaemia type 1 - A UK centre experience.
    Yeo M, Turner C, Dalton NR, Rahman Y, Vara R.
    Ann Clin Biochem; 2020 Nov 04; 57(6):412-419. PubMed ID: 32936663
    [Abstract] [Full Text] [Related]

  • 28. Pediatric liver transplantation for hepatoblastoma: a single center experience.
    Kim T, Kim DY, Kim KM, Seo JJ, Park KM, Lee YJ, Lee SG.
    Transplant Proc; 2012 Mar 04; 44(2):523-5. PubMed ID: 22410061
    [Abstract] [Full Text] [Related]

  • 29. Liver Transplant for Children With Hepatocellular Carcinoma and Hereditary Tyrosinemia Type 1.
    Bahador A, Dehghani SM, Geramizadeh B, Nikeghbalian S, Bahador M, Malekhosseini SA, Kazemi K, Salahi H.
    Exp Clin Transplant; 2015 Aug 04; 13(4):329-32. PubMed ID: 24679101
    [Abstract] [Full Text] [Related]

  • 30. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
    Piros L, Fehérvári I, Görög D, Nemes B, Szabó J, Gerlei Z, Végső G, Kóbori L, Máthé Z.
    Transplant Proc; 2015 Sep 04; 47(7):2201-6. PubMed ID: 26361680
    [Abstract] [Full Text] [Related]

  • 31. Results of pediatric liver transplantation in an originally adult liver transplant program.
    Pirenne J, Aerts R, Monbaliu D, Coosemans W, Vlasselaers D, Desmet L, Herman J, Hoffman I, Lombaerts R.
    Transplant Proc; 2007 Oct 04; 39(8):2672-4. PubMed ID: 17954204
    [Abstract] [Full Text] [Related]

  • 32. Liver transplantation for Wilson's disease.
    Sevmis S, Karakayali H, Aliosmanoglu I, Yilmaz U, Ozcay F, Torgay A, Arslan G, Haberal M.
    Transplant Proc; 2008 Oct 04; 40(1):228-30. PubMed ID: 18261593
    [Abstract] [Full Text] [Related]

  • 33. Sirolimus in pediatric liver transplantation: a single-center experience.
    Gibelli NE, Tannuri U, Pinho-Apezzato ML, Tannuri AC, Maksoud-Filho JG, Andrade WC, Velhote MC, Santos MM, Ayoub AA, Marques da Silva M.
    Transplant Proc; 2009 Apr 04; 41(3):901-3. PubMed ID: 19376384
    [Abstract] [Full Text] [Related]

  • 34. Retransplantation for late liver graft failure: predictors of mortality.
    Facciuto M, Heidt D, Guarrera J, Bodian CA, Miller CM, Emre S, Guy SR, Fishbein TM, Schwartz ME, Sheiner PA.
    Liver Transpl; 2000 Mar 04; 6(2):174-9. PubMed ID: 10719016
    [Abstract] [Full Text] [Related]

  • 35. Hepatocellular carcinoma requiring liver transplantation in hereditary tyrosinemia type 1 despite nitisinone therapy and α1-fetoprotein normalization.
    Bhushan S, Noble C, Balouch F, Lewindon P, Lampe G, Hodgkinson P, McGill J, Ee L.
    Pediatr Transplant; 2022 Nov 04; 26(7):e14334. PubMed ID: 35698261
    [Abstract] [Full Text] [Related]

  • 36. Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase.
    Lindstedt S, Holme E, Lock EA, Hjalmarson O, Strandvik B.
    Lancet; 1992 Oct 03; 340(8823):813-7. PubMed ID: 1383656
    [Abstract] [Full Text] [Related]

  • 37. Renal function in pediatric liver transplant patients.
    McDiarmid SV.
    Kidney Int Suppl; 1996 Jan 03; 53():S77-84. PubMed ID: 8770996
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics and pharmacodynamics of NTBC (2-(2-nitro-4-fluoromethylbenzoyl)-1,3-cyclohexanedione) and mesotrione, inhibitors of 4-hydroxyphenyl pyruvate dioxygenase (HPPD) following a single dose to healthy male volunteers.
    Hall MG, Wilks MF, Provan WM, Eksborg S, Lumholtz B.
    Br J Clin Pharmacol; 2001 Aug 03; 52(2):169-77. PubMed ID: 11488774
    [Abstract] [Full Text] [Related]

  • 39. Liver transplantation for polycystic liver disease.
    Pirenne J, Aerts R, Yoong K, Gunson B, Koshiba T, Fourneau I, Mayer D, Buckels J, Mirza D, Roskams T, Elias E, Nevens F, Fevery J, McMaster P.
    Liver Transpl; 2001 Mar 03; 7(3):238-45. PubMed ID: 11244166
    [Abstract] [Full Text] [Related]

  • 40. Reversibility of cirrhotic regenerative liver nodules upon NTBC treatment in a child with tyrosinaemia type I.
    Crone J, Möslinger D, Bodamer OA, Schima W, Huber WD, Holme E, Stöckler Ipsiroglu S.
    Acta Paediatr; 2003 May 03; 92(5):625-8. PubMed ID: 12839296
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.